[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 11, Issue 1 (Spring 2014 2015) ::
Sci J Iran Blood Transfus Organ 2015, 11(1): 32-40 Back to browse issues page
Association of 4G/5G polymorphism in Plasminogen activator inhibitor-inhibitor (PAI-1) gene with thrombosis in coronary arteries
M. Sakhteh, B. Poopak, N. Amirizadeh, A.R. Shamshiri, A.H. Bagheri, M. Faranoush
Keywords: Key words: Coronary Thrombosis, Myocardial Infarction, Coronary Artery Disease, PAI-1
Full-Text [PDF 283 kb]   (1773 Downloads)     |   Abstract (HTML)  (9390 Views)
Type of Study: Research | Subject: Hematology
Published: 2014/03/16
Full-Text:   (3028 Views)
References:
 
  1. Rosenberg RD, Aird WC. Vascular-bed--specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340(20): 1555-64.
  2. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342(8879): 1076-9.
  3. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95(5): 1517-32.
  4. Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, et al. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis. Thrombo Res 2012; 130(3): e43-51.
  5. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henny AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor (PAI-I) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268(15): 10739-45.
  6. Ghasemi A, Seifi M, Khosravi M. Mecanisms of Disease: Novel Polymorphism in coronary artery Disease. In: Kirac SF. Advances in the diagnosis of Coronary Atherosclerosis; 2011. p. 1-19.
  7. Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Artetrioscler Thromb 1991; 11(1): 183-90.
  8. Falk G,  Almqvist A,  Nordenhem A, Svensson H, Wiman B. Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis. 1995; 9(3): 170-4.
  9. van Wyk JT, van Wijk MA, Sturkenboom MC, Moorman PW, van der Lei J. Identification of the four conventional cardiovascular disease risk factors by Dutch general practitioners. Chest 2005; 128(4): 2521-7.
  10. Mendis Sh, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. USA: WHO; 2011. p. 295-303.
  11. Schleef RR, Higgins DL, Pillemer E, Levitt LJ. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J Clin Invest 1989; 83(5): 1747-52.
  12. Crainich P, Jenny NS, Tang Z, Arnold AM, Kuller LH, Manolio T, et al. Lack of association of plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly. J Thromb Haemost 2003; 1(8): 1799-804.
  13. Anderson JL, Muhlestein JB, Habashi J, Carlquist JF, Bair TL, Elmer SP, et al. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. J Am Coll Cardiol 1999; 34(6): 1778-83.
  14. Eriksson P, Kallin B, van 't Hooft FM, Båvenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 1995; 92(6): 1851-5.
  15. Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, et al. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case–control study. Genet Test Mol Biomarkers 2010; 14(1): 23-7.
  16. Gialeraki A, Politou M, Rallidis L, Merkouri E, Markatos C, Kremastinos D, et al. Prevalence of prothrombotic polymorphisms in Greece. Genet Test 2008; 12(4): 541-7.
  17. Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, et al. Plasminogen activator-inhibitor-1 (PAI-1) gene 4G/5G promoter polymorohism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost 2010; 16(2): 184-8.
  18. Song J, Yoon YM, Jung HJ, Hong SH, Park H, Kim JQ. Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353--> Gln polymorphism in Korean patients with coronary artery disease. J Korean Med Sci 2000; 15(2): 146-52.
  19. Onrat S, Akci O, Söylemez Z, Onrat E, Avşar A. Prevalence of myocardial infarction polymorphisms in Afyonkarahisar, Western Turkey. Mol Biol Rep 2012; 39(9): 9257-64
  20. Zhang AY, Ji XW, Zhang AJ, Guan LX, Huang J, Wang JX. Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease. Cardiol Res 2010; 1(1): 8-14.
  21. Shafiee SM, Firoozrai M, Salimi S, Zand H, Hesabi B, Mohebbi A. Angiotensin converting enzyme DD genotype not associated with increased risk of coronary artery disease in the Iranian population. Pathophisiology 2010; 17(3): 163-7.
  22. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg- Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and larg studies in whites. Arterioscler Thromb Vasc Biol 2000; 20(2): 484-92.
  23. Ahmed W, Malik M, Saeed I, Khan AA, Sadeque A, Kaleem U, et al. Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction. Mol Biol Rep 2011; 38(4): 2541-8.
 
  1. Imanian H, Hadavi V, Kariminejad A, Oberkanins CH, Najmabadi H. Study of PAI-1 4G/5G polymorphism as a genetic risk factor for cardiovascular disease in the Iranian population. Genetics in the 3rd millennium 2010; 8(1): 1973-7. [Article in Farsi]
  2. Akhter M, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, et al. Plasminogen activator-inhibitor-1 (PAI-1) gene 4G/5G promoter polymorohism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost 2010; 16(2): 184-8.
  3. Shammaa DM, Sabbagh AS, Taher AT, Zataari GS, Mahfouz RA. Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population. Mol Biol Rep 2008; 35(3): 453-7.
  4. Ahmed W, Malik M, Saeed I, Khan AA, Sadeque A, Kaleem U, et al. Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction. Mol Biol Rep 2011; 38(4): 2541-8.
  5. Margaglione M, Cappucci G, Colaizzo D, Guiliani N, Vecchione G, Grandone E, et al. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Artherioscler Thromb Vasc Biol 1998; 18(2): 152-6.
  6. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 1997; 95(1): 59-62.
 
 
 

 
 

 
 
 
 
 
Sci J Iran Blood Transfus Organ 2014; 11(1): 32-40
 
Original Article
 
 

Association of 4G/5G polymorphism in Plasminogen
 activator inhibitor-inhibitor (PAI-1) gene with
thrombosis in coronary arteries
 
Sakhteh M.1, Poopak B.2, Amirizadeh N.1, Shamshiri A.R.3, Bagheri A.H.4, Faranoush M.5
 
 
1Blood Transfusion Research Center, High Institute for Education and Research in Transfusion Medicine, Tehran, Iran
2School of Paramedicine, Tehran Medical Branch of Islamic Azad University, Tehran, Iran
3Faculty of Dendistry, Tehran University of Medical Sciences, Tehran, Iran
4Modares Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
 
 
 
Abstract
Background and Objectives
Several hereditary and acquired risk factors for thrombosis are known. Among the genetic factors, PAI-1 4G/5G polymorphism can be noted. This study was done to investigate the association of 4G/5G polymorphism in PAI-1 gene and thrombosis in coronary arteries.
 
Materials and Methods
Sixty one patients with the history of thrombosis in coronary arteries and 92 healthy blood donors participated as the control in our study. After DNA extraction from leucocytes based on the selective detergent-mediated DNA precipitation from crude lysate, PCR was performed using ARMS technique. Single and multivariate analyses were applied to adjust for potentially confounding factors using SPSS 19 software. The data were also compared with those of the other similar studies.
 
Results
The results showed 61 patients with history of coronary artery thrombosis for PAI-1 with the values of 24.6%, 45.9%, and 29.5% for 4G/4G, 4G/5G, and 5G/5G, respectively; the values for 92 healthy blood donors were evaluated to be 20.7%, 42.2%, and 37% in order. The polymorphism studied was not significantly different between cases and controls. Single and multivariate analyses show a significant difference for the conventional risk factors for coronary artery disease between patients and healthy controls (P value: 0.001).
 
Conclusions 
We found no association between arterial thrombosis and the 4G/4G genotype for PAI-1 gene in Iranian population of the current study.
 
Key words: Coronary Thrombosis, Myocardial Infarction, Coronary Artery Disease, PAI-1
 
 
 
Received: 13 May 2013
Accepted: 11 Aug 2013
 
 

Correspondence: Faranoush M., MD. Pediatrics Hematologist-Oncologist. Associate Professor of Rasoul Akram Hospital, Iran University of Medical Sciences.
P.O.Box: 14166-1157, Tehran, Iran. Tel: (+9821) 88605151; Fax: (+9821) 88601580
E-mail:
faranoush47@yahoo.com
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sakhteh M, Poopak B, Amirizadeh N, Shamshiri A, Bagheri A, Faranoush M. Association of 4G/5G polymorphism in Plasminogen activator inhibitor-inhibitor (PAI-1) gene with thrombosis in coronary arteries. Sci J Iran Blood Transfus Organ. 2015; 11 (1) :32-40
URL: http://bloodjournal.ir/article-1-853-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 1 (Spring 2014 2015) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 4419